Shukui Qin

20PUBLICATIONS
157CO-AUTHORS
Cancer diagnosisHaematological tumoursMolecular targetsBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 24, 2026
Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025).

|Feb 27, 2026
Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study.

Stephen L Chan, Thomas Yau, Robin K Kelley

|Dec 29, 2025
Erdafitinib in Patients with FGFR-Altered Advanced or Metastatic Cholangiocarcinoma.

Shubham Pant, Joon Oh Park, Wu-Chou Su

|Sep 04, 2025
Safety of fruquintinib in Chinese patients with colorectal cancer: an age subgroup analysis from a phase IV real-world clinical practice study.

Yi Wang, Yifu He, Zhiqiang Wang

|Sep 03, 2025
Safety and pharmacokinetics evaluation of oroxylin A in Chinese healthy volunteers: a phase I, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect study.

Fan Yang, Xianmin Meng, Shukui Qin

|May 16, 2025
Porustobart (HBM4003) plus Toripalimab as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma: A Multicenter, Open-Label, Phase I Study.

Ningning Zhang, Tian Liu, Ming Luo

Pageof 4

Frequent Collaborators

3 joint publications

Lin Shen

2 joint publications

Ying Cheng

2 joint publications

Ying Yuan

2 joint publications

Toshihiko Doi